Taking the recent PGC2 schizophrenia GWAS, for example,8 the defined risk loci supported the neuropsychopharmacologic hypotheses that both dopamine D2 receptor and N-methyl-D-aspartate receptor were involved in schizophrenia pathogenesis. This evidence concerns the gene DRD2 and schizophrenia.